PDF(Pubmed)
Abstract：
BACKGROUND: India\'s contribution to the malaria burden was highest in South-East Asia Region in 2021, accounting for 79% of the estimated malaria cases and 83% of malaria-related deaths. Intensified Malaria Control Programme supported by Global Funds to Fight against AIDS, Tuberculosis and Malaria has deployed crucial interventions to reduce the overall burden of malaria in India. Evaluation of utilisation of malaria elimination interventions by the community and assessment of the healthcare system is underway in eleven high malaria endemic states in India. Health system preparedness for malaria elimination, logistics, and supply chain management of diagnostic kits and anti-malarial drugs in addition to the knowledge, attitude and practice of the healthcare workers is also being assessed.
METHODS: The study is being undertaken in 11 malaria endemic states with a variable annual parasite incidence of malaria. In total, 47 districts (administrative unit of malaria control operations) covering 37 976 households are to be interviewed and assessed. We present here the protocol following which the study is being undertaken at the behest and approval of Ministry of Health and Family Welfare in India.
BACKGROUND: No patients were involved in the study. Study findings will be shared with Institutional ethics board of National Institute for Malaria Research New Delhi (NIMR) in a timely, comprehensive, accurate, unbiased, unambiguous and transparent manner and to the National Vector-borne Disease (Malaria) Control Programme officers and the Community public who participated. Important findings will be communicated through community outreach meetings which are existing in the Health system. Results will be informed to study participants via local fieldwork supervised by District Malaria Officers. Also findings will be published in reputed journals based on Indian Council of Medical Research (ICMR) publication policy.The ICMR-NIMR ethics committee approved the study via letter No. NIMR/ECM/2023/Feb/14 dated 24 April 2023 for version 5. All standard ethical practices will be followed.
METHODS: The study is being undertaken in 11 malaria endemic states with a variable annual parasite incidence of malaria. In total, 47 districts (administrative unit of malaria control operations) covering 37 976 households are to be interviewed and assessed. We present here the protocol following which the study is being undertaken at the behest and approval of Ministry of Health and Family Welfare in India.
BACKGROUND: No patients were involved in the study. Study findings will be shared with Institutional ethics board of National Institute for Malaria Research New Delhi (NIMR) in a timely, comprehensive, accurate, unbiased, unambiguous and transparent manner and to the National Vector-borne Disease (Malaria) Control Programme officers and the Community public who participated. Important findings will be communicated through community outreach meetings which are existing in the Health system. Results will be informed to study participants via local fieldwork supervised by District Malaria Officers. Also findings will be published in reputed journals based on Indian Council of Medical Research (ICMR) publication policy.The ICMR-NIMR ethics committee approved the study via letter No. NIMR/ECM/2023/Feb/14 dated 24 April 2023 for version 5. All standard ethical practices will be followed.
摘要：
背景：印度对疟疾负担的贡献在2021年东南亚区域最高，占估计疟疾病例的79%和疟疾相关死亡的83%。全球防治艾滋病基金支持的强化疟疾控制方案，结核病和疟疾已经采取了关键的干预措施，以减轻印度疟疾的总体负担。在印度的11个疟疾高流行州，正在评估社区对疟疾消除干预措施的利用情况以及对医疗保健系统的评估。卫生系统为消除疟疾做好准备，物流,以及诊断试剂盒和抗疟疾药物的供应链管理，医护人员的态度和做法也在评估中。
方法：该研究正在11个疟疾流行州进行，疟疾的年寄生虫发病率各不相同。总的来说,将采访和评估涵盖37976户家庭的47个地区（疟疾控制行动的行政单位）。我们在此介绍协议，该协议应印度卫生和家庭福利部的要求和批准进行研究。
背景：没有患者参与研究。研究结果将及时与新德里国家疟疾研究所（NIMR）的机构伦理委员会分享，全面,准确,没有偏见,明确和透明的方式，并向国家媒介传播疾病(疟疾)控制方案官员和参加的社区公众。重要的调查结果将通过卫生系统中现有的社区外展会议进行传达。结果将通过地区疟疾官员监督的当地实地考察通知研究参与者。研究结果也将发表在基于印度医学研究理事会（ICMR）出版政策的知名期刊上。ICMR-NIMR伦理委员会通过第1号信函批准了这项研究。NIMR/ECM/2023/Feb/14，日期为2023年4月24日，版本5。将遵循所有标准的道德规范。
方法：该研究正在11个疟疾流行州进行，疟疾的年寄生虫发病率各不相同。总的来说,将采访和评估涵盖37976户家庭的47个地区（疟疾控制行动的行政单位）。我们在此介绍协议，该协议应印度卫生和家庭福利部的要求和批准进行研究。
背景：没有患者参与研究。研究结果将及时与新德里国家疟疾研究所（NIMR）的机构伦理委员会分享，全面,准确,没有偏见,明确和透明的方式，并向国家媒介传播疾病(疟疾)控制方案官员和参加的社区公众。重要的调查结果将通过卫生系统中现有的社区外展会议进行传达。结果将通过地区疟疾官员监督的当地实地考察通知研究参与者。研究结果也将发表在基于印度医学研究理事会（ICMR）出版政策的知名期刊上。ICMR-NIMR伦理委员会通过第1号信函批准了这项研究。NIMR/ECM/2023/Feb/14，日期为2023年4月24日，版本5。将遵循所有标准的道德规范。
